Pathology - Dubuque, IA

Full-time position in Dubuque, Iowa (USA) with MercyOne Health Group. Part-time status will also be considered.

About the role

MercyOne Health Group is seeking a board-certified/eligible pathologist trained in both anatomic and clinical pathology. No specific subspecialty training is required; however, cytopathology training would be looked upon favorably. The successful candidate will join another pathologist and a pathologists’ assistant in Dubuque, collaborating with a collegial group of seven pathologists and two pathologists' assistants in nearby Davenport, Iowa.

The pathologists oversee and provide medical directorship for two community hospitals, a large multispecialty medical clinic, and a rural access hospital. The caseload includes approximately 14,000 surgical cases (a mixture of biopsies and resections), 2,000 non-GYN cytology cases, 8,000 GYN cytology cases, and rare autopsies. Radiologic-guided fine-needle aspirations and EBUS cases are attended for adequacy and rapid interpretation. New graduates are encouraged to apply.

Responsibilities

• Provide medical directorship for hospitals and clinics
• Oversee and interpret surgical pathology cases (biopsies and resections)
• Handle non-GYN and GYN cytology cases
• Attend radiologic-guided fine-needle aspirations and EBUS cases for adequacy and rapid interpretation
• Participate in clinical lab management and hospital committees, including tumor board

Requirements

• Board-certified or board-eligible in anatomic and clinical pathology
• Strong communication and interpersonal skills
• Commitment to building relationships with clinical colleagues
• Willingness to engage in clinical lab management and hospital committees

Benefits

• Extremely competitive compensation and benefits package
• Malpractice insurance and tail coverage provided
• Relocation assistance
• H Cap exempt status
• $100,000 sign-on bonus

Location

Dubuque, Iowa, is a city of approximately 60,000 residents located on the Mississippi River. The hospital system serves a patient base of around 140,000.